QUHUO LTD-ADR (QH)

US74841Q2093 - ADR

1.92  +0.24 (+14.29%)

After market: 1.77 -0.15 (-7.81%)


Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to QH. QH was compared to 97 industry peers in the Commercial Services & Supplies industry. QH has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, QH is valued expensive at the moment.

Note: QH has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

0


VS Industry

Valuation

Valuation Rating

3

With a price book ratio of 0.18, QH is valued rather cheaply.
Compared to an average industry price book ratio of 1.77, QH is valued rather cheaply. On top of this, QH is cheaper than 98% of the companies listed in the same industry.

The Price/Earnings Ratio is negative for QH. In the last year negative earnings were reported.
VS Industry

Price/Book (0.18) VS Industry: 98% outperformed.

15.05
0.14

Growth

Growth Rating

4

QH shows a strong growth in Revenue. In the last year, the Revenue has grown by 55.97%.
Measured over the past 5 years, QH shows a very strong growth in Revenue. The Revenue has been growing by 39.76% on average per year.

QH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -5186.37%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -5186.37% N/A N/A N/A N/A
RevenueN/A 39.76% 55.97% N/A N/A N/A N/A

Health

Health Rating

7

The Quick Ratio of QH is much better than the industry average of 1.20.
The Debt to Equity ratio of QH is way better than the industry averages. QH has a better rating than 87% of its industry peers.
QH has a Current Ratio of 1.32. This is a normal value and indicates that QH is financially healthy and should not expect problems in meeting its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.31.

QH has a Quick Ratio of 1.32. This is a normal value and indicates that QH is financially healthy and should not expect problems in meeting its short term obligations.
An Altman-Z score of 2.00 indicates that QH is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score is in line with the industry averages, which is at 1.85.
VS Industry

Debt/Equity (0) VS Industry: 87% outperformed.

31.86
0.00

Quick Ratio (1.32) VS Industry: 61% outperformed.

0.03
40.95

Current Ratio (1.32) VS Industry: 51% outperformed.

0.03
40.95

Altman-Z (2) VS Industry: 54% outperformed.

-37.85
36.05

Dividend

Dividend Rating

0

No dividends for QH!.

QUHUO LTD-ADR

NASDAQ:QH (5/26/2023, 7:00:02 PM)

After market: 1.77 -0.15 (-7.81%)

1.92

+0.24 (+14.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)12-12 2022-12-12
Earnings (Next)09-07 2023-09-07
Inst Owners0.72%
Inst Owner Change6708.56%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.84M
Analysts84.44
Price Target30.6 (1493.75%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.18
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)-3.94
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS92.48
BVpS10.66
TBVpS6.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM 4.36%
ROICexgc(3y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc(3y)N/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.99%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover3.84
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.32
Altman-Z 2
F-ScoreN/A
WACC6.75%
ROIC/WACCN/A
Cap/Depr(3y)285.76%
Cap/Depr(5y)418.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-5186.37%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-112.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1Y55.97%
Revenue growth 3Y39.76%
Revenue growth 5YN/A
Revenue growth Q2Q87.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-240.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-117.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-378.06%
OCF growth 3YN/A
OCF growth 5YN/A
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA